Brain penetration of colistin in mice assessed by a novel high-performance liquid chromatographic technique

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 10, 2009, Pages 4247-4251

  Jin, Liang ^a   Li, Jian ^a   Nation, Roger L ^a   Nicolazzo, Joseph A ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; COLISTIN; TETRAHYDROFURAN; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BOLUS INJECTION; BRAIN HOMOGENATE; BRAIN TISSUE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DETERMINATION; DRUG PENETRATION; EXPERIMENTAL STUDY; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ANIMALS; ANTI-BACTERIAL AGENTS; BLOOD-BRAIN BARRIER; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLISTIN; MALE; MICE;

EID: 70349310449     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00485-09     Document Type: Article

References (35)

1. Bergen, P. J., J. Li, C. R. Rayner, and R. L. Nation. 2006. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 50:1953-1958.
2. Beringer, P. 2001. The clinical use of colistin in patients with cystic fibrosis. Curr. Opin. Pulm. Med. 7:434-440.
3. Castel-Branco, M. M., A. M. Almeida, A. C. Falcao, T. A. Macedo, M. M. Caramona, and F. G. Lopez. 2001. Lamotrigine analysis in blood and brain by high-performance liquid chromatography. J. Chromatogr. B 755:119-127. (Pubitemid 32324076)
4. Decolin, D., P. Leroy, A. Nicolas, and P. Archimbault. 1997. Hyphenated liquid chromatographic method for the determination of colistin residues in bovine tissues. J. Chromatogr. Sci. 35:557-564.
5. Evans, M. E., D. J. Feola, and R. P. Rapp. 1999. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann. Pharmacother. 33:960-967.
6. Falagas, M. E., and S. K. Kasiakou. 2006. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit. Care. 10:R27.
7. Gump, W. C., and J. W. Walsh. 2005. Intrathecal colistin for treatment of highly resistant Pseudomonas ventriculitis. Case report and review of the literature. J. Neurosurg. 102:915-917.
8. Hancock, R. E. W., and D. S. Chapple. 1999. Peptide antibiotics. Antimicrob. Agents Chemother. 43:1317-1323.
9. Hitchcock, S. A. 2008. Blood-brain barrier permeability considerations for CNS-targeted compound library design. Curr. Opin. Chem. Biol. 12:318-323.
10. Jansson, B., M. Karvanen, O. Cars, D. Plachouras, and L. E. Friberg. 2009. Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS. J. Pharm. Biomed. Anal. 49:760-767.
11. Jiménez-Mejías, M. E., B. Becerril, F. J. Marquez-Rivas, C. Pichardo, L. Cuberos, and J. Pachon. 2000. Successful treatment of multidrug-resistant Acinetobacter baumannii meningitis with intravenous colistin sulfomethate sodium. Eur. J. Clin. Microbiol. Infect. Dis. 19:970-971.
12. Jiménez-Mejías, M. E., C. Pichardo-Guerrero, F. J. Marquez-Rivas, D. Martin- Lozano, T. Prados, and J. Pachon. 2002. Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. Eur. J. Clin. Microbiol. Infect. Dis. 21:212-214.
13. Kitagawa, T., W. Ohtani, Y. Maeno, K. Fujiwara, and Y. Kimura. 1985. Sensitive enzyme immunoassay of colistin and its application to detect residual colistin in rainbow trout tissue. J. Assoc. Off. Anal. Chem. 68:661-664.
14. Koch-Weser, J., V. W. Sidel, E. B. Federman, P. Kanarek, D. C. Finer, and A. E. Eaton. 1970. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann. Intern. Med. 72:857-868.
15. Kunin, C. M. 1970. Binding of antibiotics to tissue homogenates. J. Infect. Dis. 121:55-64.
16. Kunin, C. M., and A. Bugg. 1971. Binding of polymyxin antibiotics to tissues: the major determinant of distribution and persistence in the body. J. Infect. Dis. 124:394-400.
17. Le Brun, P. P., A. I. de Graaf, and A. A. Vinks. 2000. High-performance liquid chromatographic method for the determination of colistin in serum. Ther. Drug Monit. 22:589-593.
18. Lee, S. Y., J. W. Lee, D. C. Jeong, S. Y. Chung, D. S. Chung, and J. H. Kang. 2008. Multidrug-resistant Acinetobacter meningitis in a 3-year-old boy treated with i.v. colistin. Pediatr. Int. 50:584-585.
19. Leroy, P., D. Decolin, S. Nicolas, P. Archimbault, and A. Nicolas. 1989. Residue determination of two co-administered antibacterial agents - cephalexin and colistin - in calf tissues using high-performance liquid chromatography and microbiological methods. J. Pharm. Biomed. Anal. 7:1837-1846.
20. Li, J., R. W. Milne, R. L. Nation, J. D. Turnidge, K. Coulthard, and D. W. Johnson. 2001. A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid- phase extraction cartridges and reversed-phase high-performance liquid chromatography. J. Chromatogr. B 761:167-175. (Pubitemid 32817106)
21. Li, J., R. W. Milne, R. L. Nation, J. D. Turnidge, T. C. Smeaton, and K. Coulthard. 2003. Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration. Antimicrob. Agents Chemother. 47:1766-1770.
22. Li, J., R. L. Nation, J. D. Turnidge, R. W. Milne, K. Coulthard, C. R. Rayner, and D. L. Paterson. 2006. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis. 6:589-601.
23. Löscher, W., and H. Potschka. 2005. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2:86-98. (Pubitemid 40128029)
24. Lowman, W., T. Kalk, C. N. Menezes, M. A. John, and M. P. Grobusch. 2008. A case of community-acquired Acinetobacter baumannii meningitis - has the threat moved beyond the hospital? J. Med. Microbiol. 57:676-678.
25. Ma, Z., J. Wang, J. P. Gerber, and R. W. Milne. 2008. Determination of colistin in human plasma, urine and other biological samples using LC-MS/ MS. J. Chromatogr. B 862:205-212.
26. Metan, G., E. Alp, B. Aygen, and B. Sumerkan. 2007. Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance. J. Antimicrob. Chemother. 60:197-199.
27. Michelet, C., S. L. Leib, D. Bentue-Ferrer, and M. G. Täuber. 1999. Comparative efficacies of antibiotics in a rat model of meningoencephalitis due to Listeria monocytogenes. Antimicrob. Agents Chemother. 43:1651-1656.
28. Patrick, G. L. 2005. An introduction to medicinal chemistry, 3rd ed. Oxford University Press, Oxford, United Kingdom.
29. Quagliarello, V. J., and W. M. Scheld. 1993. New perspectives on bacterial meningitis. Clin. Infect. Dis. 17:603-608.
30. Quinn, A. L., J. P. Parada, J. Belmares, and J. P. O'Keefe. 2005. Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection. Ann. Pharmacother. 39:949-952.
31. Schwartz, B. S., M. R. Warren, F. A. Barkley, and L. Landis. 1959. Microbiological and pharmacological studies of colistin sulfate and sodium colistin methanesulfonate. Antibiot. Annu. 7:41-60.
32. Thomas, A. H., and J. M. Thomas. 1980. Use of the image analyser Optomax for the quantitative evaluation of antibiotics separated by gel electrophoresis and by thin-layer chromatography. J. Chromatogr. 195:297-302.
33. Van Bree, J. B., A. G. De Boer, M. Danhof, and D. D. Breimer. 1992. Drug transport across the blood-brain barrier. II. Experimental techniques to study drug transport. Pharm. Weekbl. Sci. 14:338-348.
34. Wan, E. C., C. Ho, D. W. Sin, and Y. C. Wong. 2006. Detection of residual bacitracin A, colistin A, and colistin B in milk and animal tissues by liquid chromatography tandem mass spectrometry. Anal. Bioanal. Chem. 385:181-188.
35. Zhang, Y., and W. M. Pardridge. 2001. Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier. J. Neuroimmunol. 114: 168-172. (Pubitemid 32184738)